Are Duetact and Baqsimi the Same Thing?
Duetact (pioglitazone hydrochloride and glimepiride) and Baqsimi (glucagon) Nasal Powder are both agents used to control blood sugar levels in patients with diabetes.
Duetact is used to control blood sugar levels for people with type 2 diabetes who do not use daily insulin injections.
Baqsimi Nasal Powder is used for emergency treatment of severe hypoglycemia in patients with diabetes ages 4 years and above and can be used by patients with both type 1 and type 2 diabetes.
Side effects of Duetact that are different from Baqsimi Nasal Powder include weight gain, diarrhea, dizziness, blurred vision, and tooth problems.
Side effects of Baqsimi Nasal Powder and Duetact that are similar include nausea, headache, and cold symptoms (sneezing, runny or stuffy nose, cough, sore throat).
Side effects of Baqsimi Nasal Powder that are different from Duetact include vomiting, upper respiratory tract irritation (i.e., nasal discomfort and nosebleed), watery eyes, eye redness, and itchy nose and eyes.
Both Baqsimi Nasal Powder and Duetact may interact with beta-blockers.
Duetact may also interact with other oral diabetes medications, albuterol, diuretics (water pills), steroids, thyroid medicines, birth control pills, and seizure medicines.
Baqsimi Nasal Powder may also interact with indomethacin and warfarin.
What Are Possible Side Effects of Duetact?
Common side effects of Duetact include:
- symptoms associated with a cold (sneezing, stuffy nose, cough, sore throat)
- weight gain
- mild nausea
- blurred vision, and
- tooth problems
What Are Possible Side Effects of Baqsimi?
Common side effects of Baqsimi include:
- upper respiratory tract irritation (i.e., runny nose, nasal discomfort, nasal congestion, cough, and nosebleed),
- watery eyes,
- eye redness,
- sneezing, and
- itchy nose, throat, and eyes
What Is Duetact?
Duetact (pioglitazone hydrochloride and glimepiride) Tablets are a combination of two oral antihyperglycemic agents used to control blood sugar levels for people with type 2 diabetes who do not use daily insulin injections.
What Is Baqsimi?
Baqsimi (glucagon) Nasal Powder is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 years and above.
What Drugs Interact With Duetact?
This and other oral diabetes medications may increase your risk of serious heart problems. Tell your doctor all medications you are taking, especially certain medication such as albuterol, beta-blockers, diuretics, steroids, thyroid medicine, birth control pills, and seizure medicine as these and other drugs can interact with Duetact. If you are pregnant or breastfeeding you should not take Duetact.
What Drugs Interact With Baqsimi?
Baqsimi Nasal Powder may interact with beta-blockers, indomethacin, and warfarin. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Baqsimi Nasal Powder; it is not expected to harm a fetus. It is unknown if Baqsimi Nasal Powder passes into breast milk. Glucagon is a peptide and would be expected to be broken down to its constituent amino acids in an infant's digestive tract and is therefore unlikely to cause harm to an exposed infant. Consult your doctor before breastfeeding.
How Should Duetact Be Taken?
Dosage of Duetact is 30 mg/2 mg or 30 mg/4 mg tablets taken once daily with food. Talk to your doctor about your individual dosage recommendation. Taking this medication for more than 1 year may increase your risk of bladder cancer.
How Should Baqsimi Be Taken?
The recommended dose of Baqsimi Nasal Powder is 3 mg administered as one pump spray of the intranasal device into one nostril.
Health Solutions From Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
FDA. Duetact Product Information.
Lilly.. Baqsimi Product Information.